are they banning semaglutide Belgium bans use of Ozempic for weight loss until summer Compounded GLP-1 ban: What providers

This dosage is used in controlled environments where detailed analysis of peptide-mediated activity is required, allowing for in-depth evaluation under well-defined experimental protocols

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines predispositions in peptide metabolic pathways, including variants affecting appetite signaling and gastrointestinal function

What's missing from a low sticker price

Jonathann Kuo, MD

The global market for GLP-1 receptor agonists was valued at USD 53.46 billion in 2024 and is expected to grow to USD 156.71 billion by 2030 , reflecting a compound annual growth rate of 17.46% between 2025 and 2030